A new prognostic score derived from phase I study participants with advanced solid tumours is also valid in patients with brain metastasis

Anticancer Research

Volumn 30, Issue 3, 2010, Pages 977-980

  Nieder, Carsten ^a,b   Dalhaug, Astrid ^a  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Albumin; Brain metastases; Lactate dehydrogenase; Prognostic score; Radiotherapy

Indexed keywords

ALBUMIN; ERLOTINIB; LACTATE DEHYDROGENASE; SUNITINIB; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; GASTROINTESTINAL TUMOR; HUMAN; KIDNEY CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; SCORING SYSTEM; SOLID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; CLINICAL TRIALS, PHASE I AS TOPIC; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; HUMANS; INDOLES; MIDDLE AGED; NEOPLASMS; PROGNOSIS; PYRROLES; QUINAZOLINES; SEVERITY OF ILLNESS INDEX;

EID: 77951050645     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nieder C and Mehta MP: Prognostic indices for brain metastases - usefulness and challenges. Radiat Oncol 4: 10, 2009.
2. Arkenau HT, Barriuso J, Olmos D, Ang JE, de Bono J, Judson I and Kaye S: Prospective validation of a prognostic score to improve patient selection for oncology phase I trials. J Clin Oncol 27: 2692-2696, 2009.
3. Chatani M, Matayoshi Y, Masaki N and Inoue T: Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase. Strahlenther Onkol 170: 155-161, 1994.
4. Paralkar VR, Li T and Langer CJ: Population characteristics and prognostic factors in metastatic non-small cell lung cancer: a Fox Chase Cancer Center retrospective. Clin Lung Cancer 9: 116-121, 2008.
5. Nieder C, Geinitz H and Molls M: Validation of the graded prognostic assessment index for surgically treated patients with brain metastases. Anticancer Res 28: 3015-3017, 2008.
6. Arkenau HT, Olmos D, Ang JE, de Bono J, Judson I and Kaye S: Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience. Br J Cancer 98: 1029-1033, 2008.
7. Nieder C, Astner ST, Grosu AL and Molls M: Evaluation of late neurologic adverse events in patients with brain metastases from non-small cell lung cancer. Anticancer Res 27: 1701-1704, 2007.
8. Meyer A, Steinmann D, Malaimare L, Karstens JH and Bremer M: Prediction of prognosis regarding fractionation schedule and survival in patients with whole-brain radiotherapy for metastatic disease. Anticancer Res 28: 3965-3969, 2008.
9. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG and Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37: 745-751, 1997.
10. Gripp S, Moeller S, Bölke E, Schmitt G, Matuschek C, Asgari S, Asgharzadeh F, Roth S, Budach W, Franz M and Willers R: Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol 25: 3313-3320, 2007.
11. Hauser CA, Stockler MR and Tattersall MH: Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review. Support Care Cancer 14: 999-1011, 2006.
12. Jacot W, Quantin X, Boher JM, Andre F, Moreau L, Gainet M, Depierre A, Quoix E, Chevalier TL and Pujol JL: Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors. Br J Cancer 84: 903-909, 2001.
13. Suh SY and Ahn HY: Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Eur J Cancer 43: 1051-1059, 2007.
14. Claude L, Perol D, Ray-Coquard I, Petit T, Blay JY, Carrie C and Bachelot T: Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma. Radiother Oncol 76: 334-339, 2005.
15. Nieder C, Pawinski A and Molls M: Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status? Clin Oncol (R Coll Radiol) 22: 65-69, 2010.